Clinical Trial Update: Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating co-administration of an investigational live-attenuated Respiratory Syncytial Virus vaccine in infants and toddlers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Investigational live-attenuated RSV vaccine (live-attenuated RSV vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: RSV Immunization | Phase 3 | Status: TERMINATED